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Abstract
To what extent is the convergent evolution of protein function attributable to convergent or parallel 
changes at the amino acid level? The mutations that contribute to adaptive protein evolution may 
represent a biased subset of all possible beneficial mutations owing to mutation bias and/or 
variation in the magnitude of deleterious pleiotropy. A key finding is that the fitness effects of 
amino acid mutations are often conditional on genetic background. This context dependence 
(epistasis) can reduce the probability of convergence and parallelism because it reduces the 
number of possible mutations that are unconditionally acceptable in divergent genetic 
backgrounds. Here, I review factors that influence the probability of replicated evolution at the 
molecular level.
The convergent evolution of organismal phenotypes is often interpreted as a testament to the 
power of natural selection to craft uniquely favoured design solutions to common problems. 
Patterns of convergence may also reflect intrinsic biases in the production of variation, as 
propensities of development can increase the likelihood that similar traits will evolve in 
different lineages1,2. An important question in evolutionary genetics concerns the extent to 
which adaptive phenotypic convergence is caused by convergent or parallel changes in the 
underlying genes. Given the typical ‘many-to-one’ mapping of genotype to phenotype, a 
corollary question concerns the causes of convergence and parallelism at the molecular 
sequence level. If there are many possible solutions to a given problem, then it is all the 
more surprising when we discover that evolution has hit upon the same solution to the same 
problem time and time again. What properties distinguish the actualized solutions from 
those of the many non-actualized possibilities? These questions have important implications 
for understanding the repeatability (and, hence, predictability) of molecular adaptation3–8.
An especially powerful approach to examine the causes of molecular convergence and 
parallelism involves the examination of phylogenetically replicated changes in protein 
function that can be traced to specific amino acid substitutions. By focusing on genetically 
based changes in a well-defined biochemical phenotype, questions about the causes of 
molecular convergence and parallelism become experimentally tractable because it is 
possible to achieve a full account of causative mutations. Moreover, reverse genetics 
approaches such as site-directed mutagenesis make it possible to measure the functional 
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effects of such mutations. Experimental studies of protein evolution therefore provide a 
manageable scale and level of focus for attempts to demarcate “…the boundary between 
predictability under invariant law and the multifarious possibilities of historical 
contingency” (REF. 9). Although I focus specifically on protein evolution in this Review, the 
same concepts are relevant to the evolution of RNA and DNA sequences.
In studies of organismal phenotypes, ‘convergence’ generally suffices as a term to describe 
the independent acquisition of similar traits in different species2,10. By contrast, the digital 
nature of molecular sequence data generally permits more refined inferences about the 
polarity of changes in character state, and it can be useful to make distinctions between 
different modes of replicated change. In comparisons between orthologous proteins from a 
given pair of species, convergent substitutions at a particular site refer to independent 
changes from different ancestral amino acids to the same derived amino acid in both species 
(FIG. 1a), whereas parallel substitutions refer to independent changes from the same 
ancestral amino acid11 (FIG. 1b). For brevity or for other principled reasons, some authors 
collectively refer to both types of replicated substitution as convergence12–14.
Strictly defined, convergent and parallel substitutions involve the fixation of identical-by-
state alleles in different lineages; the alleles have independent mutational origins. 
Comparative studies of naturally evolved proteins have documented a number of striking 
cases of convergence and parallelism at the amino acid level, several of which involved 
experimental validation of presumably adaptive functional effects. These include studies of 
phylogenetically replicated substitutions in the visual opsins of various vertebrate species 
that mediate evolutionary transitions in spectral sensitivity15,16, substitutions in the 
haemoglobins of high-altitude Andean hummingbirds that mediate evolutionary transitions 
in blood-oxygen affinity, substitutions in Na+,K+-ATPase enzymes of herbivorous insects 
that mediate resistance to toxic, plant-derived cardenolides18,19, substitutions in Na+,K+-
ATPase enzymes in squamate reptiles that mediate resistance to cardiac glycosides produced 
by toxic prey species20, and substitutions in voltage-gated sodium channel (Nav1) proteins in 
reptiles, amphibians and fish that mediate resistance to tetrodotoxin21,22. There are also 
numerous examples of molecular convergence and parallelism in proteins that mediate 
insecticide resistance23,24, herbicide resistance25 and antibiotic resistance26. In addition to 
comparative studies, experimental evolution studies involving microorganisms and viruses 
have documented remarkable cases of replicated amino acid substitutions during adaptation 
to novel environmental challenges27–32.
In addition to the replicated fixation of identical-by-state alleles that have independent 
mutational origins, the sharing of identical-by-descent alleles between species may be 
attributable to incomplete lineage sorting or introgressive hybridization; either way, the 
shared alleles do not have independent mutational origins, so the gene tree will not be 
congruent with the inferred species tree. As a result of this genealogical discordance, 
substitutions that are mapped onto the species tree (as opposed to the underlying gene tree) 
can make it look like single transitions in character state actually occurred multiple times 
independently. This phenomenon is termed ‘hemiplasy’33,34 to distinguish it from the true 
homoplasy produced by convergent and parallel substitutions. In the presence of hemiplasy, 
the phylogenetic replication of character-state transitions may be more apparent than real, as 
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it simply results from forcing the discordant gene tree to conform to the branching topology 
of the species tree34 (BOX 1).
Box 1
Hemiplasy affects inferences about phenotypic convergence
Genealogical discordance between gene trees and species trees affects inferences about 
the number and timing of character-state transitions, potentially resulting in the incorrect 
inference of convergence where none has occurred (termed hemiplasy)33,34. In the 
example shown in the figure (left panel), a set of three species (X, Y and Z) have retained 
an allelic polymorphism that was present in their last common ancestor (the ‘1’ allele is 
derived). As a result of incomplete lineage sorting, the identical-by-descent ‘1’ alleles do 
not coalesce in the common ancestor of the sister species X and Y, and instead coalesce 
in the last common ancestor of species X, Y and Z, thereby producing genealogical 
discordance between the gene tree ((X,Z),Y)) and the species tree ((X,Y),Z)). Mapping 
the 0→1 substitution onto the gene tree indicates a single character-state transition 
(middle panel). However, if the gene tree is assumed to be congruent with the topology of 
the species tree (right panel), then the phyletic distribution of character states produces 
the appearance that the 0→1 change occurred twice independently (once in the branch 
leading to species X and once in the branch leading to species Z, yielding so-called 
‘collateral substitutions’7). Thus, the 0→1 substitution and any associated change in 
phenotype only appear to be phylogenetically replicated if we force the discordant gene 
tree to fit the species tree. This highlights the potentially illusory nature of ‘collateral 
substitutions’ and illustrates how incomplete lineage sorting can be mistaken for 
convergence when gene tree discordance is not taken into account34. Incomplete lineage 
sorting and the resultant hemiplasy in trait evolution is most likely to occur in sets of 
species that have undergone a relatively rapid radiation, such that time intervals between 
successive speciation events (that is, internodal times in the species tree) are short relative 
to effective population sizes124,125.
Here, I review factors that influence the probability of replicated substitutions in protein 
evolution. In addition to addressing questions of longstanding interest about the repeatability 
and predictability of evolutionary change, this topic is timely because there is currently a 
great deal of excitement about using whole-genome sequence data to test for evidence of 
adaptive molecular convergence and parallelism.
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Causes of substitution bias
There are two main reasons why we might expect adaptive convergence in protein function 
to involve convergent or parallel substitutions at the amino acid level. First, it may be that 
there are simply a limited number of mutations capable of producing the requisite change in 
phenotype, reflecting intrinsic constraints imposed by the nature of structure–function 
relationships. This could be considered the ‘forced option’ hypothesis. Alternatively, it may 
be that there are many possible mutations that can produce the requisite change in 
phenotype, but particular mutations (or particular types of mutation) are preferentially fixed. 
This substitution bias may be attributable to variation in rates of origin; that is, sites vary in 
rates of mutation to alleles that produce the beneficial change in phenotype (mutation bias), 
or mutations with similar main effects on the selected phenotype vary in their probability of 
fixation once they arise (fixation bias) owing to variation in the magnitude of deleterious 
pleiotropy6.
The probability of parallel substitution between two species, which both choose the next 
mutational step from the same distribution of n possible options (each with probability p(i)), 
is:
(1)
It follows that
(2)
where n is the number of possible options and V is the variance in the probabilities of those 
options. Equivalently,
(3)
where C is the coefficient of variation in the probabilities (see equation 8b in Chevin et al.5 
for a similar formulation). In biological terms, n is the number of possible mutations, and C 
subsumes the effects of all mutational and selective factors that increase variability in the 
distribution of fixation probabilities of the n possible mutations. For a given n, the 
probability of parallel substitution is minimized if all n mutations occur at equal rates and if 
they all have identical selection coefficients; that is, Pr(//)=1/n when C = 0. The probability 
of parallel substitution increases linearly with decreasing n, and it increases monotonically 
with increasing C.
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How might we go about estimating these key parameters that influence the probability of 
parallel substitution? Experimental insights into the effective number of mutations that are 
capable of producing a given change in protein function can be obtained via reverse-genetic 
screens of engineered mutational libraries, and insights into the causes of substitution bias 
can be obtained via directed evolution experiments and/or comparative studies of naturally 
evolved proteins. In comparative studies of orthologous proteins from multiple species, we 
can assess whether particular mutations or particular types of mutations have been fixed 
preferentially by testing whether average substitution rates are the same across sites6 (BOX 
2). Below, I discuss potential causes of mutation bias and fixation bias.
Box 2
Are some mutations preferentially fixed during adaptive evolution?
Within a given gene, the mutations that contribute to adaptive modifications of protein 
function may represent a biased subset of all possible mutations that are capable of 
producing the same functional effect. For example, there may be numerous amino acid 
mutations that can produce the same adaptive improvement in the catalytic activity of an 
enzyme, but these mutations may be unequal in the eyes of natural selection if they vary 
in the magnitude of deleterious pleiotropy. Thus, mutations that have equivalent main 
effects on a selected phenotype may still have different selection coefficients (and, hence, 
different fixation probabilities). To assess whether particular types of amino acid 
mutation are preferentially fixed, we can test whether average substitution rates are the 
same for different mutation classes (for example, mutations in the active site versus 
mutations affecting protein allostery)6. In the simplest possible ‘origin-fixation’ model of 
molecular evolution, the substitution rate is given by:
(4)
where N is the size of a diploid population, μ is the per-copy rate of mutation, and is the 
probability that a new mutation becomes fixed once it has arisen. In this framework, we 
can specify the substitution rate as the product of the rate at which new alleles originate 
via mutation and the probability that they become fixed in the population once they 
arise39,126. This model is based on the ‘infinite sites’ assumption that each new mutation 
occurs at a site where variation is not currently segregating127. The origin-fixation 
formalism therefore describes a regime of mutation-limited evolution where the rate of 
evolution is directly proportional to the mutation rate39.
An important implication is that a bias in mutation rates can produce a bias in 
substitution rates, even when the substitutions are driven by positive selection35–37,39. In 
the absence of contributions from standing variation, a bias in rates of origin affects the 
joint probability of origin and fixation. As μ and λ can vary among different classes of 
mutations, site-specific substitution rates will vary accordingly126, so the expected rate of 
substitution for mutations in class i is Ki= 2Nμiλi. The class-specific mutation rate is μi = 
μθi, where μ is the overall rate of origin for mutations that produce a given change in 
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phenotype and θi is the proportion of these mutations in class i, yielding Ki= 2Nμθiλi. 
Thus, the proportion of fixed mutations in class i is
(5)
We can assess evidence for substitution bias by testing whether each mutation class 
contributes equally to evolutionary changes in a particular protein function; that is, we 
can test the null hypothesis that ri= 1/n for all i. In a comparison between two discrete 
mutation classes, i and j, substitution bias is indicated if the different types of mutation 
have unequal rates of origin (θi ≠ θj) and/or unequal probabilities of fixation once they 
arise (λ i ≠ λj). The role of mutation bias can be assessed by testing the null hypothesis 
that θi= 1/n for all i. Using data from mutagenesis screens, the role of fixation bias can be 
assessed by testing the null hypothesis that the spectrum of spontaneous mutations that 
produce a given change in protein function is equal to the spectrum of substitutions that 
are responsible for evolutionary changes in protein function between species6.
For comparisons between different classes of site (or different classes of mutational 
change or mutational effect), this framework provides a means of assessing the extent to 
which an observed substitution bias is attributable to biased mutation rates and/or biased 
fixation probabilities6,35,37, and can therefore provide insights into possible causes of 
convergent and parallel substitutions during adaptive protein evolution.
Mutation bias as a cause of substitution bias
An under-explored question in evolutionary genetics concerns the extent to which mutation 
bias influences pathways of adaptive molecular evolution35–37. For example, in mammalian 
genomes the combination of transition:transversion bias and CpG bias results in especially 
high rates of C→T and G→A transition mutations. The genetic code then determines how 
these propensities of nucleotide change translate into propensities of amino acid change38. 
As explained in BOX 2, mutation bias can be an important orienting factor in both neutral 
and adaptive molecular evolution because an asymmetry in rates of origin can affect the joint 
probability of origin and fixation35–37,39.
Results of several experimental evolution studies have provided evidence that mutation bias 
can influence trajectories of adaptive protein evolution29,40–43; however, this has not been 
systematically investigated. In repeated single-step adaptive walks involving the same wild-
type genotype of a single-strand DNA bacteriophage, ID11, the two amino acid mutations 
that fixed in the largest fraction of replicate lines did not have the largest selection 
coefficients but they were produced by mutationally favoured C→T transitions. By contrast, 
the fittest allele — which was fixed at a relatively lower rate — was produced by a 
mutationally unfavoured G→T transversion29. In this system, fixation probabilities could be 
accurately predicted by adjusting a model of origin-fixation dynamics (BOX 2) to 
incorporate the estimated transition:transversion bias.
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Similar effects have been documented in studies of natural variation. For example, 
experiments on native haemoglobin variants and engineered, recombinant haemoglobin 
mutants demonstrated that a nonsynonymous mutation at a highly mutable CpG dinucleotide 
in the βA-globin gene of high-altitude Andean house wrens (Troglodytes aedon) contributed 
to an adaptive increase in haemoglobin-oxygen affinity, thereby enhancing blood-oxygen 
transport capacity under hypoxia44. There seems little reason to suppose that the causative 
amino acid mutation would have had a larger selection coefficient (and, hence, a higher 
fixation probability) than any number of other possible mutations that could have produced 
the same adaptive modification of protein function. However, if the rate of CpG mutation 
occurs at a higher rate than non-CpG mutations, then — in the absence of contributions from 
standing variation — the bias in mutation rate is expected to influence evolutionary 
outcomes in the same way as a commensurate bias in fixation probability35,37,39.
Fixation bias as a cause of substitution bias: the role of pleiotropy
Amino acid mutations commonly have pleiotropic effects on protein biochemistry as they 
can simultaneously affect multiple aspects of molecular function, structural stability, folding, 
solubility and propensity for aggregation45–52. Consequently, mutations that improve one 
aspect of protein function may simultaneously compromise other structural or functional 
properties. Within the set of mutations that have functionally equivalent effects on a selected 
biochemical phenotype, those that incur a lower magnitude of deleterious pleiotropy should 
have a higher fixation probability5,53, and may therefore contribute disproportionately to 
phenotypic evolution. Investigations into the genetic basis of evolutionary transitions in 
floral pigmentation in angiosperm plants provide evidence in support of this hypothesis6.
Patterns of replicated substitution in duplicated genes can also provide insight into the 
influence of pleiotropic constraints on fixation bias. Among the diverse insect taxa that have 
independently evolved resistance to toxic cardenolides via genetic changes in Na+,K+-
ATPase, a preponderance of parallel substitutions occurred in those taxa that possess a single 
Na+,K+-ATPase gene (FIG. 2). In those taxa that possess two copies of the gene, a greater 
number of unique (non-shared) substitutions appeared to contribute to convergence in 
cardenolide resistance19. A possible explanation for this pattern is that the possession of two 
functionally redundant paralogues alleviates pleiotropic constraints, so a broader spectrum 
of function-altering mutations could be tolerated in one copy or the other and could 
therefore potentially contribute to adaptation.
Pleiotropic constraints are often invoked to explain patterns of convergent and parallel 
molecular evolution3,4,7,19,54,55, but these inferences are often based on fairly indirect lines 
of evidence. Decisive tests of the deleterious pleiotropy hypothesis require direct, 
experimental measurements of the effects of individual mutations on a selected phenotype in 
conjunction with experimental measurements of mutational pleiotropy in the same genetic 
background45,52,56–58. This requires a decision about which particular molecular phenotypes 
to measure. Experimental assessments of mutational pleiotropy therefore require insight into 
the nature of possible trade-offs and an understanding of the biologically relevant 
dimensionality of phenotypic space for the protein in question.
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Consideration of the role of pleiotropic constraints on molecular adaptation highlights a key 
difference between two alternative experimental approaches for investigating mechanisms of 
protein evolution. In directed evolution experiments, libraries of randomly mutagenized gene 
products are iteratively screened and selected for a desired biochemical property (for 
example, improved catalytic activity or novel substrate specificity)59–61. The advantage of 
this approach is that it permits the evaluation of a vast and unbiased set of mutant proteins, 
and can reveal large numbers of possible mutations that are capable of producing a particular 
change in function. The alternative strategy involves retrospective analysis of natural or 
laboratory evolution. This strategy explores a far more circumscribed region of sequence 
space, and is best suited to the goal of identifying the specific historical substitutions that 
caused changes in protein function in realized evolutionary pathways. In retrospective 
analyses, the protein under consideration will have evolved under pleiotropic constraints that 
are manifest in vivo, and adaptive modifications of particular functional properties may be 
more likely to require compromise-based solutions in the joint optimization of different 
structural and functional properties.
Intramolecular epistasis
Non-uniformity of mutational effects at orthologous sites
During the adaptive evolution of protein function, epistasis can affect the fixation 
probabilities of function-altering mutations in two ways: first, the effect of the mutation on a 
positively selected phenotype may be conditional on genetic background; and second, the 
pleiotropic effects of the mutation may be conditional on genetic background. In principle, 
both forms of epistatic interaction can influence which mutations contribute to molecular 
adaptation.
Protein engineering studies have documented pervasive epistasis between mutant sites in the 
same protein, both with respect to specific biochemical phenotypes58,62–71 and — in 
microbial and viral experimental evolution studies — with respect to fitness or fitness 
proxies8,40,48,56,72–81. An especially powerful experimental approach involves the synthesis 
of ‘combinatorially complete’ sets of recombinant mutants representing all possible 
mutational intermediates connecting a given pair of ancestral and derived alleles82. The chief 
merit of this approach is that additive and non-additive effects of amino acid changes can be 
quantified by testing each individual mutation in all possible multi-allelic combinations. 
Such protein engineering studies have demonstrated that the same mutations sometimes have 
opposite phenotypic effects on different genetic backgrounds — a phenomenon known as 
‘sign epistasis’83. One consequence of sign epistasis is that the fitness effects of amino acid 
mutations will depend on the sequential order in which they occur during the course of an 
adaptive walk. A mutation that increases fitness on the ancestral genetic background (for 
example, when it occurs as the first step in an adaptive walk) may have neutral or deleterious 
effects on a background in which other substitutions have already occurred.
Sign epistasis can exert a deterministic effect on protein evolution by constraining the 
number of selectively accessible mutational pathways to high-fitness genotypes, thereby 
enhancing the repeatability of substitutions that represent intermediate steps in such 
pathways8,74,83. This notion of deterministic repeatability appears to be the basis for 
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assertions that epistasis should generally increase the probability of molecular convergence 
and parallelism7,84. However, this form of repeatability applies specifically to replicated 
changes among independent iterations of the evolutionary process that are initiated with the 
same ancestral genotype. By contrast, questions about the causes of molecular convergence 
and parallelism in natural protein evolution generally pertain to replicated changes among 
lineages that evolved from disparate ancestral starting points. In comparisons of orthologous 
proteins in different species, sign epistasis for fitness should typically decrease the 
probability of convergence and parallelism, because a mutation that has a beneficial effect 
on the genetic background of one species will have a neutral or deleterious effect on the 
divergent genetic backgrounds of other species. Adaptive convergence and parallelism 
would only be expected for (non-sign-epistatic) mutations that retain their beneficial effects 
across all backgrounds.
Consider a pair of parallel substitutions that occur at the same site in orthologous proteins of 
two closely related species. If orthologues of the two species are identical or nearly identical 
in sequence, then the parallel substitutions are likely to have similar phenotypic effects 
(ignoring the possibility of intergenic epistasis). However, if the same substitution occurs in 
a more distantly related species, then it will be more likely to have a phenotypic effect that is 
different in magnitude or sign, simply because there would be more opportunity for 
divergence in sequence context (or, more specifically, there would be more opportunity for 
divergence at sites that epistatically interact with the focal residue than there would be in a 
closely related species). Convergent or parallel substitutions at orthologous sites in different 
species may have different fitness effects owing to lineage-specific changes in the fitness 
landscapes of individual residue positions (FIG. 3a). As a given site can be occupied by up 
to 20 amino acids, the set of fitness values conferred by each possible variant defines a 
vector of site-specific amino acid propensities for a given genetic background85–87. This 
single-position fitness landscape can be considered a cross-section of the complete fitness 
landscape (FIG. 3b), and can change through time owing to changes in the environment 
and/or changes in genetic background (FIG. 3c).
In addition to reducing the probability of convergent and parallel substitutions at 
orthologous sites, context-dependent fitness effects of mutations can make substitutions 
conditionally irreversible64,71,85,87–91. Even if a given substitution was beneficial, neutral or 
nearly neutral when it initially occurred, mutational reversions to the ancestral state may 
eventually become maladaptive owing to subsequent changes in sequence context — a 
phenomenon termed ‘entrenchment’87. Thus, epistasis can be expected to reduce levels of 
molecular homoplasy by decreasing the probability of convergent and parallel changes to a 
shared, derived state and by decreasing the probability of mutational reversions to the 
ancestral state.
The above considerations suggest that epistasis may often reduce probabilities of molecular 
convergence and parallelism because it reduces the number of possible mutations that have 
unconditionally acceptable effects in divergent genetic backgrounds. As explained below, 
research on compensatory mutations has provided strong evidence for the pervasiveness of 
such context-dependent fitness effects.
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Compensatory substitutions
Pleiotropic trade-offs can give rise to a context dependence of mutational effects as 
evidenced by cases where the fitness impact of a given mutation is determined by 
compensatory (conditionally beneficial) mutations at other sites in the same protein. For 
example, the selective fixation of function-altering mutations that confer a net fitness benefit 
may select for compensatory mutations to mitigate deleterious pleiotropic effects of the 
functional change46,92,93. Alternatively, function-altering mutations may be selectively 
permissible only on a background in which the requisite compensatory (or ‘permissive’) 
mutations have already occurred47,52,63,68,94–96. These compensatory mutations are neutral 
or deleterious on their own; they are only beneficial in combination with the function-
altering mutation.
In addition to experimental evidence for sign-epistatic interactions between mutant sites in 
the same protein, sign epistasis for fitness is indirectly implicated in cases where pathogenic 
amino acid variants in one species are observed as wild type in orthologous proteins of other 
species97–105. The inference is that the deleterious effect of the mutation in the focal species 
is mitigated by one or more compensatory substitutions in the orthologue of the other 
species. More direct evidence for sign-epistatic effects comes from cases where a given 
substitution has an experimentally well-documented effect on protein function in one 
species, but it has a different phenotypic effect when it occurs at the orthologous site in 
another species. For example, two lineages of foregut-fermenting mammals, ruminant 
artiodactyls and colobine monkeys, have convergently evolved digestive RNases with 
reduced ribonuclease activity against double-stranded RNA. However, these convergent 
changes in ribonuclease activity were caused by different amino acid substitutions, and one 
substitution that produced a significant increase in ribonuclease activity in the ruminant 
RNase produced the opposite effect in the monkey RNase106. Investigations into the 
evolution of spectral sensitivity in vertebrate opsins have revealed numerous cases where 
identical substitutions in the homologues of different species shift the wavelength of 
maximal absorbance in opposite directions16. Similarly, spontaneous mutations at highly 
conserved carboxy-terminal residue positions in the β-chain of human haemoglobin are 
known to completely abolish the Bohr effect (the pH sensitivity of haemoglobin-oxygen 
affinity), a deleterious reduction of allosteric regulatory control that compromises tissue-
oxygen delivery. Surprisingly, however, identical substitutions at homologous sites in the 
haemoglobins of crocodilians107, birds108 and ground squirrels109 do not compromise the 
Bohr effect.
Sign epistasis and nonlinearity of the phenotype-fitness map
In principle, sign epistasis for fitness can stem directly from the non-additivity of mutational 
effects on a selected phenotype, in which case nonlinearity in the mapping of genotype to 
phenotype gives rise to nonlinearity in the mapping of phenotype to fitness. However, even 
when mutations have additive effects on phenotype, sign epistasis for fitness can result from 
a nonlinear relationship between phenotype and fitness46,72,78,80,87,110,111. Sign epistasis for 
fitness is therefore an inherent property of stabilizing selection even if causative mutations 
have strictly additive effects on the selected phenotype (FIG. 4). This has important 
implications for understanding how epistasis influences probabilities of molecular 
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convergence and parallelism. Consider a pair of species that are adapting to a shared 
selection pressure. Even if a given mutation has identical phenotypic effects in the two 
species, it will have different effects on fitness if the two species start out at different 
distances from the phenotypic optimum (FIG. 4). This effect of sign epistasis illustrates how 
stochastic vagaries of history can reduce the probability of molecular convergence and 
parallelism111. The mapping function that relates phenotype to fitness will inevitably vary 
from one species to the next owing to idiosyncratic differences in population size and past 
histories of selection, so the same mutations may often have different effects on fitness 
(thereby reducing the likelihood that they would contribute to adaptive convergence) even 
when they have identical effects on the selected phenotype.
Tests of repeated molecular adaptation
Molecular homoplasy can be produced by chance as each amino acid site in a protein has 
only 20 possible character states. In practice, a far more restricted number of amino acids 
can generally be tolerated at any given residue position, so the effective number of possible 
character states will typically be far less than 20 (REFS 11,14,85,112–116). Many parallel 
sequence changes in protein evolution involve neutral or nearly neutral back-and-forth 
exchanges between physicochemically similar amino acids that can be interconverted by 
single mutational steps11,38,112,113. As nonrandom patterns of molecular homoplasy can be 
produced by mutation bias and/or purifying selection that constrains substitutions to a 
restricted number of exchangeable amino acids, clear evidence is required to invoke positive 
selection as a cause of molecular convergence and parallelism.
Zhang117 listed four requirements for establishing that convergent or parallel substitutions 
are responsible for adaptive convergence in protein function: replicated substitutions are 
observed in independent lineages; the proteins under investigation have independently 
evolved derived changes in function; replicated substitutions are responsible for the 
convergent changes in protein function; and the number of replicated substitutions is greater 
than expected by chance alone. Most claims of adaptive molecular convergence and 
parallelism satisfy one or two of these requirements, and the third requirement on the list 
(establishing a causal connection between change in sequence and change in phenotype) is 
the one that most often remains unfulfilled because it requires experimental data on the 
functional effects of individual substitutions.
Experimental approaches
Surveys of sequence variation in the haemoglobin genes of Andean waterfowl revealed 
numerous amino acid substitutions that occurred in parallel in different high-altitude 
lineages118. The authors concluded that these parallel substitutions must have contributed to 
adaptive increases in haemoglobin-oxygen affinity (which would enhance arterial oxygen-
loading under hypoxia), although the postulated functional effects were not experimentally 
validated. The parallel substitutions in the waterfowl globin genes were highlighted as 
‘hotspots’ for molecular adaptation and were cited in support of the claim that available 
adaptive solutions were constrained owing to the ‘limited number of effective mutations’55. 
However, a subsequent study by Natarajan et al.108 experimentally measured the phenotypic 
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effects of each of the putatively adaptive substitutions and demonstrated that only one of the 
parallel changes actually contributed to a convergent increase in haemoglobin-oxygen 
affinity in separate highland taxa. Most convergent increases in haemoglobin-oxygen affinity 
in highland taxa were attributable to unique substitutions, and most parallel substitutions 
were functionally inconsequential with respect to the oxygenation properties of 
haemoglobin108. This highlights the importance of experimentally validating claims about 
molecular adaptation, and demonstrates why convergence and parallelism at the amino acid 
level should not be interpreted as prima facie evidence for positive selection on protein 
function. It seems likely that many published claims about adaptive molecular convergence 
and parallelism would not hold up under experimental scrutiny, as few comparative studies 
of naturally evolved proteins have rigorously tested the functional effects of putatively 
causative substitutions. Upon closer inspection, many convergent and parallel substitutions 
at sites that are assumed to be ‘hotspots’ of molecular adaptation55 may turn out to be 
nothing more than hotspots of neutral homoplasy.
Null models for testing adaptive molecular convergence and parallelism
Rigorous assessments of the prevalence of adaptive molecular convergence and parallelism 
require a properly formulated null model. This is highlighted by a recent study that claimed 
to have documented genome-wide convergence in protein-coding genes in two mammalian 
lineages that have independently evolved the capacity for echolocation: microchiropteran 
bats and toothed whales119. Re-analysis of the data using appropriate null models revealed 
no preponderance of convergent substitutions in the two lineages120,121, refuting the 
conclusions of the original study. In fact, the re-analyses actually revealed a lower level of 
genome-wide convergence in the comparison between microbats and toothed whales than in 
comparisons between microbats and equally divergent non-echolocating mammals120,121.
Zou and Zhang116 analysed genome-wide alignments of protein-coding genes from a 
number of eukaryotic taxa to assess whether observed levels of molecular convergence and 
parallelism could generally be explained without invoking positive selection. For the 
alignment of each set of orthologous sequences, they estimated branch lengths of the tree 
(based on known phylogenetic relationships of the species under consideration), the 
substitution rate of each site relative to the average across the entire protein, and ancestral 
sequences for each internal node of the phylogeny. For each pair of 1:1 orthologues between 
a given pair of species, they then compared the inferred number of replicated substitutions 
with neutral expectations derived from several different substitution models (BOX 3). The 
most simple substitution model was based on average substitution patterns across many 
proteins, where expected equilibrium frequencies of the 20 amino acids were set equal to the 
observed frequencies in the protein under consideration. Under this simple model, the 
observed numbers of convergent and parallel substitutions were significantly higher than the 
null expectation. At face value, this result could be uncritically interpreted as evidence for 
pervasive positive selection that favoured the same sequence changes in different lineages. 
However, the authors obtained a different result when they used a more sophisticated model 
that accounted for the fact that different sites in a protein are subject to different 
physicochemical constraints, such that the particular amino acids that are acceptable at one 
site may be different from those that are acceptable at another site (the equilibrium 
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frequencies of the 20 amino acids were set equal to the observed frequencies at each site 
across all sequences in the alignment, rather than averaging across sites). Under this model, 
the observed number of convergent and parallel substitutions did not exceed the neutral 
expectation116.
Box 3
Null models for testing adaptive molecular convergence and parallelism
How do we test whether observed levels of molecular convergence and parallelism are 
attributable to positive selection using comparative sequence data? That is, how do we 
formulate a rigorous neutral expectation?
Consider an alignment of orthologous sequences of a given enzyme from a set of six 
species, the phylogenetic relationships of which are depicted in the figure. Suppose that 
species C and species F have convergently evolved derived increases in the catalytic 
activity of the enzyme. We want to assess whether the convergent functional changes in 
the enzyme were caused by convergent or parallel substitutions, and we want to assess 
whether it is necessary to invoke positive selection to explain the observed patterns of 
replicated substitution. That is, we want to test whether the numbers of convergent or 
parallel substitutions along the two thick branches in the figure exceed the neutral 
expectation11,116. The first step is to infer the ancestral amino acids at all internal nodes 
of the phylogeny for each site in the amino acid alignment. The total number of sites that 
have undergone replicated substitutions on the thick branches is tallied up as the 
‘observed’ number of such substitutions.
Assuming that amino acid substitutions at a site follow a Markov process, we can 
compute the probabilities of convergent and parallel substitutions along the thick 
branches given the following: a rate matrix of amino acid substitutions; the rate of 
substitution at the focal site relative to the average rate across all sites in the alignment; 
the equilibrium frequencies of each amino acid; and estimates of branch lengths based on 
the expected number of substitutions per site. The expected number of sites with 
convergent or parallel substitutions is the sum of these probabilities across all sites. Using 
this framework, the observed and expected numbers of convergent and parallel 
substitutions can be computed using a probabilistic model of amino acid substitution. The 
choice of model is important for formulating an appropriate neutral expectation. In 
particular, recent empirical and simulation studies have demonstrated the importance of 
using substitution models that account for variation in functional constraint among sites 
and site-specific changes in functional constraint through time14,116.
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These results demonstrate the importance of using substitution models that account for site-
specific variation in functional constraints, reflected by among-site heterogeneities in 
equilibrium amino acid frequencies, and changes in the nature of those constraints through 
time14,85,116. Analyses that are based on simple time-averaged and site-averaged substitution 
models underestimate the expected number of replicated substitutions under neutrality, and 
can therefore lead to spurious inferences about the prevalence of adaptive molecular 
convergence and parallelism.
Rates of parallelism decrease with time
Another key finding to emerge from model-based studies of protein evolution is that the 
number of parallel substitutions tends to decrease as a function of sequence 
divergence14,86,88,89,112,115,116. This pattern may be attributable to pervasive epistatic 
interactions among sites in the same protein, as changes in site-specific functional 
constraints occur as a result of changes in sequence context52,85–87,89,90,114–116. In the 
presence of intramolecular epistasis, the set of amino acids that is acceptable at a given site 
depends on which amino acids are present at interacting sites. Orthologous sites in the 
proteins of different species will gradually diverge in the sets of mutually acceptable amino 
acids owing to divergence in sequence context. Thus, epistasis reduces the probability that 
the same substitution will be acceptable at orthologous sites in different species, and this 
probability is expected to decrease as a function of sequence divergence.
Although intramolecular epistasis is a plausible cause of the apparent decline in molecular 
parallelism as a function of divergence time, it will be important to confirm that this 
explanation is robust to the effects of genealogical discordance caused by incomplete lineage 
sorting. Recent preliminary work122 demonstrates that analysing substitutions on discordant 
gene trees in the context of a single fixed species tree can produce the appearance that single 
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substitutions have occurred twice independently — an artefactual result that could lead to 
misleading inferences about the prevalence of molecular parallelism.
Summary and future outlook
The number of possible mutations that are capable of producing an adaptive change in 
protein function depends on the particular protein under consideration and the nature of the 
selected biochemical phenotype. If adaptive modifications of protein function require fine-
tuned changes in catalytic activity or substrate specificity, then the number of potentially 
adaptive mutations may be limited to a fairly restricted set of active-site residues (with 
regard to equation 3, n would be small). If the adaptive change involves a more generalized 
property, such as thermostability or net charge, then numerous possible mutations at 
numerous possible sites may be capable of producing the requisite change (n would be 
larger). The former scenario involves fewer degrees of freedom and is therefore expected to 
involve a higher frequency of convergent or parallel substitutions. The probability of 
replicated substitution may be further enhanced by variation among sites in the rate at which 
beneficial alleles originate, and by variation in their probabilities of fixation once they arise, 
owing to variation in dominance coefficients or the magnitude of deleterious pleiotropy. 
These factors would increase the coefficient of variation in fixation probabilities (increasing 
C in equation 3).
Results of protein-engineering experiments demonstrate that the particular mutations that 
could potentially contribute to adaptive improvements in a given protein function may often 
depend on the particular amino acids that are present at other sites in the same protein. As 
the phenotypic effects of function-altering changes are often context-dependent — and as 
orthologous proteins of different species provide different sequence contexts to the extent 
that they have diverged owing to drift and/or lineage-specific selection pressures — the 
number and identity of potentially acceptable mutations can be expected to vary from one 
lineage to the next. Thus, epistasis may generally reduce the probability of molecular 
convergence and parallelism in orthologues of different species.
Whole-genome sequencing will continue to provide a starting point for many comparative 
and experimental studies of molecular convergence and parallelism. For comparative studies 
of naturally evolved proteins, increasingly sophisticated modelling approaches are needed to 
assess whether it is necessary to invoke positive selection to explain observed patterns of 
molecular convergence and parallelism. Although computational analyses of sequence 
variation will continue to play a key part in suggesting hypotheses, experimental appraisals 
of putatively causative mutations are needed to provide definitive tests of those hypotheses. 
Functional experiments provide the most decisive means of adjudicating claims about the 
adaptive significance of replicated substitutions, and can provide direct, mechanistic insights 
into the causes of genetic constraints on adaptation. Moreover, as answers to fundamental 
questions about the genetics of adaptation require data that speak in terms of “...individual 
mutations that have individual effects” (REF. 123), experimental approaches that involve 
direct measurements of mutational effects are essential.
Storz Page 15
Nat Rev Genet. Author manuscript; available in PMC 2017 June 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Acknowledgments
The author thanks M. W. Hahn, M. J. Harms, D. McCandlish, M. D. Rausher, A. Stoltzfus and anonymous 
reviewers for helpful suggestions. This work was supported by grants from the US National Institutes of Health 
(HL087216) and the US National Science Foundation (MCB-1517636 and IOS-0949931).
Glossary
Orthologous
A form of homologous relationship between genes from different species, indicating that 
they trace their common ancestry back to speciation events (represented by internal nodes of 
the species tree) rather than gene duplication events.
Fixation
The process by which the frequency of a mutant allele increases to 100% in a population, 
thereby supplanting the ancestral allele.
Identical-by-state
The identity of allelic gene copies that is attributable to independent mutational changes to a 
shared character state. The alleles in question have independent mutational origins.
Cardenolides
Plant-derived steroidal toxins that have an important role in defence against insect 
herbivores by inhibiting the Na+/K+-ATPase enzyme.
Identical-by-descent
The identity of allelic gene copies that is attributable to direct descent from a single-copy 
ancestral allele. The alleles in question have a single mutational origin.
Incomplete lineage sorting
The retention of ancestral polymorphism from one population-splitting event to the next, 
followed by stochastic sorting of allelic lineages among descendant species. A common 
cause of genealogical discordance between gene trees and species trees.
Introgressive hybridization
The incorporation of allelic variants from one species into the gene pool of another species 
via hybridization and repeated backcrossing.
Genealogical discordance
Topological discrepancies among the allelic genealogies (gene trees) of different loci in the 
same organismal phylogeny.
Homoplasy
Sharing of character states between species that is attributable to convergence, parallelism, 
or evolutionary reversal rather than direct inheritance from a common ancestor.
Pleiotropy
The phenomenon where the same mutation (or genetic locus) affects multiple phenotypes.
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Selection coefficients
Measures of the relative fitnesses of particular genotypes in comparison with a reference 
genotype in a defined environment.
Transition:transversion bias
The commonly observed excess of transition mutations (exchanges between purine DNA 
bases [A↔G] or between pyrimidine bases [C↔T]) relative to transversion mutations 
(exchanges between purines and pyrimidines).
CpG bias
If the DNA nucleotide cytosine (C) is immediately 5′ to guanine (G) on the same coding 
strand (a so-called ‘CpG’ dinucleotide), and if the C is methylated to form 5′-
methylcytosine, then C→T and G→A transition mutations occur at an elevated rate relative 
to mutations at non-CpG sites.
Adaptive walks
Adaptive evolution that occurs via the sequential fixation of beneficial mutations. The 
process can be conceptualized as the movement of a population through genotype space via 
discrete mutational steps, following a trajectory of progressively increasing fitness.
Nonsynonymous mutation
A point mutation in coding sequence that causes an amino acid replacement in the encoded 
protein.
Standing variation
Allelic variation that is currently segregating in a population, as opposed to allelic variants 
produced by de novo mutation.
Epistasis
Non-additive interactions between alleles at two or more loci, such that the phenotypic effect 
of the different alleles in combination cannot be predicted by the sum of the individual 
effects of each allele by itself.
Stabilizing selection
Selection on phenotypic variation that favours intermediate trait values.
Purifying selection
Selection that removes deleterious allelic variants.
Equilibrium frequencies
Expected frequencies of amino acids in a given sequence or at each site within a sequence. 
In most models of amino acid sequence evolution, the frequencies are assumed to remain 
constant over the time period under consideration.
Markov process
A ‘memoryless’ process of stochastic change with the property that future states depend 
only on the present state, not on the sequence of antecedent states.
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Figure 1. Convergent and parallel substitutions: phylogenetically replicated changes that involve 
different mutational paths
a | In comparisons among orthologous proteins from a given set of species, convergent 
substitutions at a particular site refer to independent changes from different ancestral amino 
acids to the same derived amino acid. In this case, there was a change from G (the ancestral 
state) to T (the derived state) in one species, and a change from A to T in another species. 
The convergent substitutions are denoted by red bold lines. b | Parallel substitutions at a site 
refer to independent changes from the same ancestral amino acid to the same derived amino 
acid. In this case, changes from A to T occurred in two different species. The parallel 
substitutions are denoted by red bold lines. In sets of closely related species, parallelism is 
generally more common than convergence simply because — at any given site — close 
relatives will be more likely to share the same ancestral state prior to the occurrence of 
independent substitutions.
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Figure 2. Phylogenetic patterns of parallel and unique substitutions in ATPα1 that are associated 
with resistance to toxic cardenolides in herbivorous insects
Substitutions at the indicated sites in Na+,K+-ATPase α1 subunit (ATPα1) are implicated in 
cardenolide-binding in insect taxa that feed on Apocynaceae. Names of insect orders are 
shown on the far right. Numbered columns correspond to sites that are implicated in 
cardenolide-binding based on experimental evidence. Grey sites correspond to sites that may 
have a role in cardenolide-binding based on structural considerations. Dots denote identity 
with the consensus sequence. Outgroup sequences of vertebrate Na+,K+-ATPase α1 subunit 
(ATP1A1; a homologue of ATPα1) from several taxa (sheep, pig and spiny dogfish) are 
shown for reference. Letters in red boxes represent amino acid replacements whose 
functional effects have been experimentally characterized. Underlined letters are 
substitutions that require at least two nonsynoymous substitutions relative to the ancestral 
sequence. Orange-shaded rows correspond to specialists that are known to sequester 
cardenolides. Grey-shaded rows represent species that either are not known to sequester 
cardenolides and/or are nonspecialists that are only occasionally found on Apocynaceae. 
Green circles represent inferred duplications of the gene encoding ATPα1. Numbers at the 
bottom of the figure correspond to the number of inferred substitutions associated with use 
of Apocynaceae. Red boxes at the bottom of the figure correspond to parallel substitutions 
(observed in more than one independent lineage). Blue boxes correspond to unique 
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substitutions (observed in only one lineage). Note that a preponderance of parallel 
substitutions occurs only in taxa that possess a single copy of the gene encoding ATPα1. In 
those taxa that possess two duplicate copies, a greater number of unique (nonshared) 
substitutions have occurred. It may be that the possession of two functionally redundant 
paralogues alleviates pleiotropic constraints, so a broader spectrum of function-altering 
mutations can contribute to adaptation. A. nerii, Aphis nerii; A. pisum, Acyrthosiphon 
pisum; B. mori, Bombyx mori; B. tabaci, Bemisia tabaci; B. trivittata, Boisea trivittata; C. 
auratus, Chrysochus auratus; C. castaneus, Cyrtepistomus castaneus; C. lectularius, Cimex 
lectularius; C. tenera, Cycnia tenera; D. citri, Diaphorina citri; D. eresimus, Danaus 
eresimus; D. gilippus, Danaus gilippus; D. plexippus, Danaus plexippus; E. egle, Euchaetes 
egle; H. melpomene, Heliconius melpomene; L. archippus, Limenitis archippus; L. caryae, 
Lophocampa caryae; L. clivicollis, Labidomera clivicollis; L. halia, Lycorea halia; L. kalmii, 
Lygaeus kalmii; M. robiniae, Megacyllene robiniae; O. aries, Ovis aries; O. faciatus, 
Oncopeltus fasciatus; P. chalceus, Pogonus chalceus; P. glaucus, Papilio glaucus; P. 
versicolora, Plagiodera versicolora; R. lineaticollis, Rhyssomatus lineaticollis; S. acanthias, 
Squalus acanthias; S. scrofa, Sus scrofa; T. castaneum, Tribolium castaneum; T. legitima, 
Trichordestra legitima; T. tetrophthalmus, Tetraopes tetrophthalmus. Adapted from Zhen, Y., 
Aardema, M. L., Medina, E. M., Schumer, M. & Andolfatto, P. Parallel molecular evolution 
in an herbivore community. Science 337, 1634–1637 (2012). Reprinted with permission 
from the American Association for the Advancement of Science.
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Figure 3. Schematic depiction of how single-position fitness landscapes change through time
Horizontal rows correspond to each of the 20 possible amino acids at each site in a protein. a 
| At each site, the currently predominant amino acid (shown in bold outline) confers high 
fitness. b | The single-position fitness landscape of site 7, shown in isolation. c | Temporal 
change in the single-position fitness landscape. The relative fitness levels of different amino 
acids at the position change through time owing to changes in the genetic background (that 
is, substitutions at other sites) and/or changes in the environment. The depicted changes in 
fitness are modelled as a Poisson process. Adapted from Bazykin, G. A. Changing 
preferences: deformation of single position amino acid fitness landscapes and evolution of 
proteins. Biology Letters (2015) 11, 20150315, by permission of the Royal Society.
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Figure 4. Mutations with additive effects on phenotype can have epistatic effects on fitness
As a result of nonlinearity in the relationship between phenotype and fitness, mutations with 
additive effects on phenotype can have epistatic effects on fitness. In this hypothetical 
example, the same mutation is introduced into three genotypes (labelled a, b and c on the 
figure) that have different phenotypes. The mutation has the same phenotypic effect (Δp = 1) 
on each of the three backgrounds, but the change in fitness (Δw) is different in each case. 
The mutation increases fitness in genotypes a and b (although the magnitude of the 
increment is different) and it reduces fitness in genotype c. Adapted from REF. 111.
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